Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)
Clinical trial NCT01463696 · TERMINATED
Trial details
- NCT number
- NCT01463696
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-21
- Primary completion
- 2014-09-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.